Voyageur Pharmaceuticals Ltd. is a Canadian developer and commercial supplier of barium-based medical-imaging contrast products pursuing a vertically integrated mineral-to-pharmaceutical supply chain. Its wholly owned Frances Creek barite project in British Columbia has a 2022 PEA, an active pre-feasibility program and a pending five-year bulk-sample application. Voyageur also holds the Jubilee Mountain polymetallic property and a 90% interest in the ULI lithium and iodine brine property in Utah, and is advancing Bayer-backed feasibility work for modular iodine extraction from U.S. oilfield brines. Its five Health Canada-licensed barium products began generating commercial sales in 2025 using imported barium sulfate and third-party manufacturing.
- Country
- Canada
- Stage
- Developer